Aktie 4117 GENERAL BIOLOGICALS CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen General Biologicals Corporation

Aktien

4117

TW0004117007

4117

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 13.05.2024 		% 5 Tage % 1. Jan.
19,65 TWD -0,76 % Intraday Chart für General Biologicals Corporation -2,72 % -27,22 %
30.04. General Biologicals Corporation meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 General Biologicals Corporation meldet Gewinnergebnisse für das Halbjahr bis zum 30. Juni 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2022
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
General Biologicals Corporation(TPEX:4117) dropped from S&P Global BMI Index
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2021
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
General Biologicals Corporation completed the acquisition of additional 77% stake in Pacgen Life Science Corporation.
General Biologicals Corporation(TPEX:4117) added to S&P Global BMI Index
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2020
General Biologicals Corporation announced that it has received TWD 77.623729 million in funding from Hong Kong Chlitina International Limited
General Biologicals Corporation entered into a letter of intent to acquire additional 77% stake in Pacgen Life Science Corporation for CAD 1.4 million.
General Biologicals Corporation Announces Develops Covid-19 Testing Solutions for Antigen and Antibody Detection
Savior Lifetec : Taiwanese companies fill US demand for medical supplies amid pandemic
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2019
General Biologicals Corporation Reports Earnings Results for the Half Year Ended June 30, 2019
General Biologicals Corporation Reports Earnings Results for the Full Year Ended December 31, 2018
General Biologicals Corporation Adds New Markets for P113 Products Licensed from Pacgen
GBC Introduces its New Discovery Line of Document Cameras
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4117 Aktie
  4. Nachrichten General Biologicals Corporation
  5. Andere Sprachen